GTHCX Mutual Fund

NAV$17.94

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.82%
Dividend Yield (Current)
12.26%
Holdings
81
Inception Date
Mar 1, 1999
Fund Family
Invesco (US)
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+2.99%
1 Year+15.29%
3 Year+10.13%
5 Year+10.73%
10 Year+14.07%

Asset Allocation

Stocks: 95.79%
Cash: 4.21%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co9.07%
JNJJohnson & Johnson5.81%
AZN:LNAstraZeneca PLC4.34%
GILDGilead Sciences Inc4.10%
ABBVAbbvie Inc3.67%
Top 10 Concentration: 42.62%Report Date: Mar 31, 2026
Download all 81 holdings for GTHCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
12.26%
Frequency
Annually
Latest Distribution
$9.93
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

GTHCX Mutual Fund Overview

GTHCX Mutual Fund (Invesco Health Care Fund Class C) is managed by Invesco (US). GTHCX expense ratio is 1.82%, holding 81 positions across sectors including Health Care, Unknown, Real Estate. Inception date: 1999-03-01.

GTHCX performance shows a YTD return of 2.99%. The 1-year return is 15.29% and the 5-year return is 10.73%. GTHCX dividend yield stands at 12.26%, paid annually.

GTHCX top holdings include Eli Lilly & Co (9.1%), Johnson & Johnson (5.8%), AstraZeneca PLC (4.3%), Gilead Sciences Inc (4.1%), Abbvie Inc (3.7%). View all GTHCX holdings, sector breakdown, or dividend history.

GTHCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GTHCX alternatives are available via the screener, along with tax-loss harvesting opportunities.